Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2020 Jun 25;150(2):268–269. doi: 10.1002/ijgo.13252

Universal screening for SARS‐CoV‐2 in asymptomatic obstetric patients in Tokyo, Japan

Daigo Ochiai 1, * ,, Yoshifumi Kasuga 1, * , Miho Iida 1, Satoru Ikenoue 1, Mamoru Tanaka 1
PMCID: PMC9087702  PMID: 32496574

Short abstract

The prevalence of COVID‐19 in asymptomatic obstetric patients in Tokyo was shown to be 4% when universal screening was implemented. Physicians should pay attention to asymptomatic patients to prevent nosocomial infections.

Keywords: COVID‐19, Novel coronavirus, Pregnancy


Asymptomatic transmission of SARS‐CoV‐2 is a major issue in healthcare settings, and management in perinatal wards requires particular caution. Located in central Tokyo as a tertiary center, Keio University Hospital implemented universal PCR testing on patients before admission starting April 6 2020, in response to a nosocomial outbreak of COVID‐19. The present study reports a retrospective review of 52 obstetric patients universally tested for SARS‐CoV‐2 admitted to this hospital between April 6 and April 27, 2020.

PCR test results were confirmed in all patients prior to admission, except for two who were in labor before testing. The two patients were isolated and treated in negative‐pressure rooms until results confirmed them negative. Of the 52 women, none presented with symptoms of COVID‐19, yet two (3.8%) were confirmed positive when tested using PCR, and one (1.9%) was treated as positive due to close contact with her COVID‐19‐confirmed husband. For these patients, we performed elective cesarean deliveries in negative‐pressure operation rooms after obtaining informed consent, followed by postpartum care in isolation rooms. The patients remained asymptomatic, with subsequent repeated negative PCR results. The newborns were admitted to the NICU isolation area with negative ventilation; none tested positive for SARS‐CoV‐2 after birth (Table 1).

Table 1.

PCR‐confirmed and clinically suspicious cases of SARS‐CoV‐2.

Case Age PCR (mother) GA Covid‐19 symptom PH BW (g) Apgar (1/5 min) PCR (neonate) Note
1 33 Positive 39 + 4 None None 3715 7/8 Negative None
2 32 Positive 37 + 2 None None 2805 8/9 Negative None
3 31 Negative 37 + 2 None Hypothyroidism 2998 9/9 Negative Husband: PCR‐positive

Abbreviations: Apgar, Apgar score; BW, birth weight; GA, gestational age (weeks + days); PH, past history.

Our findings showed that the prevalence of COVID‐19 in Tokyo among asymptomatic obstetric patients (4%) was low in comparison with other cities such as New York, where prevalence was reported to be 13%. 1 Since the number of positive cases had likely been underestimated due to the government’s policy of solely testing symptomatic cases in Japan, the present data might offer an estimation of the asymptomatic proportion of COVID‐19 in the area. Additionally, the research highlighted the importance of preventing viral shedding from certain asymptomatic cases with regard to nosocomial infection. 2

Management of COVID‐19 obstetric patients can be greatly affected by the characteristics of a facility, such as the number of deliveries and medical staff, availability of effective isolation environments and personal protective equipment (PPE), and the crisis situation. Although there is no definitive evidence of negative‐pressure delivery rooms reducing nosocomial infections, ISUOG guidance recommends them for confirmed cases. 3 In our case, the hospital was under extreme burden of dealing with a widespread nosocomial outbreak, which led to scarcities of staffing and PPE. However, by universally testing patients before admission and determining isolation practices based on screening results, we were able to prevent transmission of SARS‐CoV‐2 within the perinatal ward while maintaining the function of a tertiary care hospital.

AUTHOR CONTRIBUTIONS

DO, YK, and MT were involved in the conceptualization, investigation, writing of the original draft, and editing and review of the manuscript. MI and SI were involved in the writing, review, and editing, and investigation of the study. MT was also responsible for the supervision of the study.

CONFLICTS OF INTEREST

The authors have no conflicts of interest.

REFERENCES

  • 1. Sutton D, Fuchs K, D'Alton M, Goffman D. Universal screening for SARS‐CoV‐2 in women admitted for delivery. N Engl J Med. 2020;382:2163–2164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26:672–675. [DOI] [PubMed] [Google Scholar]
  • 3. Poon LC, Yang H, Lee JCS, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55:700–708. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Gynaecology and Obstetrics are provided here courtesy of Wiley

RESOURCES